Cargando…

Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups

OBJECTIVE: The European Society of Gynaecological Oncology (ESGO)-quality indicators (QIs) for advanced ovarian cancer (AOC) have been assessed only by few Italian centers, and data are not available on the proportion of centers reaching the score considered for a satisfactory surgical management. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Greggi, Stefano, Falcone, Francesca, Aletti, Giovanni D., Cascella, Marco, Bifulco, Francesca, Colombo, Nicoletta, Pignata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428297/
https://www.ncbi.nlm.nih.gov/pubmed/35712972
http://dx.doi.org/10.3802/jgo.2022.33.e60
_version_ 1784779083783077888
author Greggi, Stefano
Falcone, Francesca
Aletti, Giovanni D.
Cascella, Marco
Bifulco, Francesca
Colombo, Nicoletta
Pignata, Sandro
author_facet Greggi, Stefano
Falcone, Francesca
Aletti, Giovanni D.
Cascella, Marco
Bifulco, Francesca
Colombo, Nicoletta
Pignata, Sandro
author_sort Greggi, Stefano
collection PubMed
description OBJECTIVE: The European Society of Gynaecological Oncology (ESGO)-quality indicators (QIs) for advanced ovarian cancer (AOC) have been assessed only by few Italian centers, and data are not available on the proportion of centers reaching the score considered for a satisfactory surgical management. There is great consensus that the Enhanced Recovery After Surgery (ERAS) approach is beneficial, but there is paucity of data concerning its application in AOC. This survey was aimed at gathering detailed information on perioperative management of AOC patients within MITO-MaNGO Groups. METHODS: A 66-item questionnaire, covering ESGO-QIs for AOC and ERAS items, was sent to MITO/MaNGO centers reporting to operate >20 AOC/year. RESULTS: Thirty/34 questionnaires were analyzed. The median ESGO-QIs score was 31.5, with 50% of centers resulting with a score ≥32 which provides satisfactory surgical management. The rates of concordance with ERAS guidelines were 46.6%, 74.1%, and 60.7%, respectively, for pre-operative, intra-operative, and post-operative items. The proportion of overall agreement was 61.3%, and with strong recommendations was 63.1%. Pre-operative diet, fasting/bowel preparation, correction of anaemia, post-operative feeding and early mobilization were the most controversial. A significant positive correlation was found between ESGO-QIs score and adherence to ERAS recommendations. CONCLUSION: This survey reveals a satisfactory surgical management in only half of the centers, and an at least sufficient adherence to ERAS recommendations. Higher the ESGO-QIs score stronger the adherence to ERAS recommendations, underlining the correlations between case volume, appropriate peri-operative management and quality of surgery. The present study is a first step to build a structured platform for harmonization within MITO-MaNGO networks.
format Online
Article
Text
id pubmed-9428297
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-94282972022-09-07 Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups Greggi, Stefano Falcone, Francesca Aletti, Giovanni D. Cascella, Marco Bifulco, Francesca Colombo, Nicoletta Pignata, Sandro J Gynecol Oncol Original Article OBJECTIVE: The European Society of Gynaecological Oncology (ESGO)-quality indicators (QIs) for advanced ovarian cancer (AOC) have been assessed only by few Italian centers, and data are not available on the proportion of centers reaching the score considered for a satisfactory surgical management. There is great consensus that the Enhanced Recovery After Surgery (ERAS) approach is beneficial, but there is paucity of data concerning its application in AOC. This survey was aimed at gathering detailed information on perioperative management of AOC patients within MITO-MaNGO Groups. METHODS: A 66-item questionnaire, covering ESGO-QIs for AOC and ERAS items, was sent to MITO/MaNGO centers reporting to operate >20 AOC/year. RESULTS: Thirty/34 questionnaires were analyzed. The median ESGO-QIs score was 31.5, with 50% of centers resulting with a score ≥32 which provides satisfactory surgical management. The rates of concordance with ERAS guidelines were 46.6%, 74.1%, and 60.7%, respectively, for pre-operative, intra-operative, and post-operative items. The proportion of overall agreement was 61.3%, and with strong recommendations was 63.1%. Pre-operative diet, fasting/bowel preparation, correction of anaemia, post-operative feeding and early mobilization were the most controversial. A significant positive correlation was found between ESGO-QIs score and adherence to ERAS recommendations. CONCLUSION: This survey reveals a satisfactory surgical management in only half of the centers, and an at least sufficient adherence to ERAS recommendations. Higher the ESGO-QIs score stronger the adherence to ERAS recommendations, underlining the correlations between case volume, appropriate peri-operative management and quality of surgery. The present study is a first step to build a structured platform for harmonization within MITO-MaNGO networks. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022-06-03 /pmc/articles/PMC9428297/ /pubmed/35712972 http://dx.doi.org/10.3802/jgo.2022.33.e60 Text en © 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Greggi, Stefano
Falcone, Francesca
Aletti, Giovanni D.
Cascella, Marco
Bifulco, Francesca
Colombo, Nicoletta
Pignata, Sandro
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title_full Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title_fullStr Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title_full_unstemmed Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title_short Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
title_sort evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from mito-mango groups
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428297/
https://www.ncbi.nlm.nih.gov/pubmed/35712972
http://dx.doi.org/10.3802/jgo.2022.33.e60
work_keys_str_mv AT greggistefano evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT falconefrancesca evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT alettigiovannid evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT cascellamarco evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT bifulcofrancesca evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT colombonicoletta evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups
AT pignatasandro evaluationofperioperativemanagementofadvancedovariantubalperitonealcancerpatientsasurveyfrommitomangogroups